131 related articles for article (PubMed ID: 25918062)
1. High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions.
Mangiacapra F; Cavallari I; Ricottini E; Pellicano M; Barbato E; Di Sciascio G
Int J Cardiol; 2015; 190():124-5. PubMed ID: 25918062
[No Abstract] [Full Text] [Related]
2. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Nardin M; Bellomo G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
[TBL] [Abstract][Full Text] [Related]
3. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
4. Residual platelet reactivity after clopidogrel loading in ST-elevation myocardial infarction patients undergoing a delayed catheterization. Impact on long term clinical events.
Vavuranakis M; Kalogeras K; Dagres N; Kariori M; Vrachatis D; Moldovan C; Lavda M; Mpei E; Androulakis A; Siasos G; Tousoulis D; Stefanadis C
Int J Cardiol; 2014 Oct; 176(3):1292-3. PubMed ID: 25129275
[No Abstract] [Full Text] [Related]
5. Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention.
Mangiacapra F; Patti G; Peace A; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Muller O; Barbato E; Di Sciascio G
Am J Cardiol; 2010 Sep; 106(5):619-23. PubMed ID: 20723634
[TBL] [Abstract][Full Text] [Related]
6. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
[TBL] [Abstract][Full Text] [Related]
7. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
[TBL] [Abstract][Full Text] [Related]
8. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Bellomo G; Marino P; Sinigaglia F; De Luca G
J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
[TBL] [Abstract][Full Text] [Related]
9. Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study.
Alexopoulos D; Makris G; Xanthopoulou I; Patsilinakos S; Deftereos S; Gkizas V; Perperis A; Karanikas S; Angelidis C; Tsigkas G; Koutsogiannis N; Hahalis G; Davlouros P
Circ Cardiovasc Interv; 2014 Apr; 7(2):233-9. PubMed ID: 24668226
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
[TBL] [Abstract][Full Text] [Related]
11. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Parodi G; Bellandi B; Xanthopoulou I; Capranzano P; Capodanno D; Valenti R; Stavrou K; Migliorini A; Antoniucci D; Tamburino C; Alexopoulos D
Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552565
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E
J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370
[TBL] [Abstract][Full Text] [Related]
13. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
[TBL] [Abstract][Full Text] [Related]
14. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Zeng RX; Li JJ; Liao PD; Zhang MZ
Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
[TBL] [Abstract][Full Text] [Related]
15. Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.
Wang TY; Henry TD; McCoy LA; Berger PB; Cohen DJ; Effron MB; Zettler M; Baker BA; Messenger JC; Peterson ED
Am Heart J; 2015 Oct; 170(4):706-14. PubMed ID: 26386794
[TBL] [Abstract][Full Text] [Related]
16. Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial Infarction.
Małek ŁA; Kłopotowski M; Śpiewak M; Woźniak K; Waś J; Miśko J; Rużyłło W; Witkowski A
Clin Appl Thromb Hemost; 2014 Jul; 20(5):553-8. PubMed ID: 23344994
[TBL] [Abstract][Full Text] [Related]
17. Persistent enhanced platelet activation in patients with acute myocardial infarction and coronary microvascular obstruction: clinical implications.
Aurigemma C; Scalone G; Tomai F; Altamura L; De Persio G; Stazi A; Lanza GA; Crea F
Thromb Haemost; 2014 Jan; 111(1):122-30. PubMed ID: 24085158
[TBL] [Abstract][Full Text] [Related]
18. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
Verdoia M; Camaro C; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
[TBL] [Abstract][Full Text] [Related]
20. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting.
Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM
Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
